Mesenchymal Stem Cells Guide

Overview

An Overview of Stem Cells

Explore the science, applications, and benefits of stem cells for advanced healthcare solutions.

Related: How they work • Clinical benefits

Foundation

What are stem cells?

Stem cells are at the foundation of regenerative medicine, offering a natural way to repair, regenerate, and restore damaged tissues. With their unique properties of self-renewal and the ability to differentiate into specialized cells, stem cells hold invaluable potential in modern medicine. For medical professionals, understanding the basics of stem cells, the types, mechanisms, and clinical applications, along with the current state of research, is essential for navigating this rapidly evolving field.

Stem cells are programmed to secrete growth factors, signaling molecules and cell communication signals that are involved in regeneration and repair of specific tissues. For example, cardiac progenitor cells get attracted towards the heart by following distress signals secreted by the damaged areas of the tissue and repair that organ.

Stem cells exist in all multicellular organisms and play a critical role in development, growth, and tissue repair. Their applications range from fundamental research to clinical therapies, targeting injuries, degenerative diseases, and even certain forms of cancer.

Self-Renewal	Differentiation
Stem cells can divide and produce identical copies over extended periods.	They can develop into specific cell types, such as muscle, bone, or nerve cells, depending on the body's needs. This ability to repair and regenerate tissues makes them invaluable for therapeutic applications.

Explore the benefits

Classification

Types of stem cells

From perinatal mesenchymal lines to pluripotent lines-each category carries distinct origins, potency, and clinical context. We exclusively offer MSCs, which are by far the most potent, versatile, and ethically sourced type of stem cell.

Perinatal Stem Cells (MSCs)

Source: Derived from perinatal tissues like Umbilical Cord Tissue, placenta, and amniotic fluid, collected immediately after birth.

Potency: Multipotent, able to differentiate into various cells such as bone, cartilage, and fat.

Applications and Ethical Advantage

They are effective for immune modulation and tissue regeneration and widely researched for therapeutic uses.
Perinatal MSCs are ethically favorable as they are obtained from tissues typically discarded after childbirth.

Induced Pluripotent Stem Cells (iPSCs)

Source: Created by reprogramming adult cells, such as skin cells, into a pluripotent state.

Potency: Pluripotent, with the ability to differentiate into nearly any cell type.

Advantages and Limitations

iPSCs offer an ethical alternative to ESCs, as they do not require embryos.
However, they face challenges related to stability and potential mutations, which must be addressed before widespread clinical use.

Adult Stem Cells (ASCs)

Source: Found in tissues like bone marrow, blood, fat, and muscle, often referred to by their tissue origin (e.g., hematopoietic stem cells for blood).

Potency: Multipotent, meaning they can differentiate into a limited number of cell types within a specific tissue family.

Applications

Blood disorders (e.g., bone marrow transplants)
Orthopedic injuries
Some autoimmune conditions
Fewer ethical concerns and are widely accepted in both research and clinical settings

Embryonic Stem Cells (ESCs)

Source: Derived from embryos, typically created through in vitro fertilization and not intended for implantation.

Potency: Pluripotent, meaning they can become almost any cell type in the body.

Ethical and Regulatory Concerns

Derived from human embryos, raising ethical and moral questions.
Their usage is highly regulated, making them less commonly applied in clinical settings.

Sourcing

Allogenic vs. autologous

Stem cells may come from a matched donor or from the patient's own tissue. Each pathway shapes immune compatibility, logistics, and therapeutic design.

1. Allogenic

Source: Collected from a donor, often from umbilical cord tissue, bone marrow, or other sources.

Immune Compatibility: Chosen for their "immune privilege," meaning they are less likely to be rejected by the immune system.

Advantages

Higher regenerative potential, especially with younger or perinatal cells.
Immediate availability, with banked cells ready for use.
Standardized dosing and quality in cell banks.

Limitations

Risk of immune reaction, though rare with MSCs.
Disease screening is necessary to minimize transmission risks.

2. Autologous

Source: Collected from the patient's own body, typically from bone marrow or adipose tissue.

Immune Compatibility: No risk of immune rejection, as they are from the patient's own body.

Advantages

Reduced immune rejection risk.
Lower risk of disease transmission.
Lower ethical concerns for some patients.

Limitations

May have reduced regenerative capacity in older patients due to cellular aging.
Collection can be invasive, requiring procedures like bone marrow aspiration or liposuction.

Collection methods

Umbilical Cord and Placental Tissue Collection

Process: Collected immediately after birth from donated umbilical cords and placenta.
Applications: Widely used in regenerative medicine due to immune privilege and high regenerative potential.
Considerations: Safe, non-invasive, and ethically favorable.

Bone Marrow Aspiration

Process: A needle is inserted into the pelvis to aspirate bone marrow.
Applications: Common for blood disorders and orthopedic applications.
Considerations: Requires anesthesia, can be moderately painful, with a recovery period.

Adipose (Fat) Tissue Harvesting

Process: Liposuction is performed to obtain fat tissue, then processed to extract stem cells.
Applications: Used in cosmetic and orthopedic treatments.
Considerations: Minimally invasive but involves surgical conditions.

Wharton's Jelly

Why Do We Use Wharton's Jelly MSCs?

Wharton's Jelly (WJ) is the gelatinous connective tissue of the umbilical cord. It harbors a uniquely primitive population of MSCs that display characteristics intermediate between fetal and adult stem cells. WJ-MSCs express the canonical MSC surface markers (CD90⁺, CD73⁺, CD105⁺) while being negative for hematopoietic markers (CD34⁻, CD45⁻, HLA-DR⁻). Critically, they express pluripotency-associated transcription factors (Oct-4, Sox-2, Nanog) at higher levels than adult bone marrow or adipose-derived MSCs — conferring superior proliferative capacity, telomere length, and differentiation range.

Peer-reviewed studies confirm that WJ-MSCs exhibit lower immunogenicity than adult MSCs, with near-absent MHC Class II expression enabling safe allogeneic use without HLA matching or immunosuppression in most protocols. A landmark review by Dominici et al. and subsequent studies confirm the MSC marker constellation; a 2020 review in Cells demonstrated WJ-MSC paracrine outputs (IL-10, TGF-β, IDO, PGE2) exceed those of bone marrow counterparts across immunomodulatory assays.^[1] Phenotypic characterization studies further confirm WJ-MSCs retain this marker profile and paracrine output through extended culture, supporting manufacturing consistency at scale.^[2]

Manufacturing Standard

Akira's Manufacturing Standard

Parameter	Akira Biotech Specification
Donor Age	First-pregnancy mothers, 18–29 years
Delivery Method	Elective C-section only (controlled environment)
Screening	3-generation family history, comprehensive maternal bloodwork, normal female karyotype (46,XX)
Passage	Maximum P2 (Passage 2) — preserves telomere length & potency
Cryopreservation	Glucose-based, DMSO-free medium
Post-Thaw Viability	>98%+ by trypan blue exclusion
Manufacturing Standard	cGMP-compliant facility
Culture Media	Bovine serum-free, animal-derived product-free
QC Testing	Flow cytometry (CD90, CD73, CD105 positive; CD34, CD45, HLA-DR negative); mycoplasma; sterility; endotoxin
Differentiation Confirmation	Lineage-specific markers verified by immunofluorescence and qPCR prior to release

How They Work

How stem cells work

Discover the three fundamental mechanisms that make stem cells powerful agents for repair, rejuvenation, and chronic disease management.

Related: Overview • Clinical benefits

Direct Differentiation

Step 1 of 3: Direct differentiation

In specific cases, stem cells differentiate directly into required cell types to repair damaged tissues. For example, MSCs can differentiate into cartilage cells, aiding in joint repair.

Tissue-Specific Repair: Stem cells transform into the exact cell type needed for repair, such as bone cells for fractures or cartilage cells for joint damage. In osteoarthritis models, intra-articular injection results in cartilage matrix deposition within weeks, confirmed by type II collagen immunostaining.

Targeted Regeneration: This direct approach ensures that new, healthy cells replace damaged or diseased tissue with precision. In cardiac models, MSCs undergo trans-differentiation toward cardiomyocyte-like cells in peri-infarct zones, though this occurs at a low, non-physiological level.^[3] Direct differentiation is most established in mesenchymal tissues (osteogenic, chondrogenic, adipogenic lineages), where it works alongside paracrine mechanisms.

Clinical Applications: Used in orthopedic treatments, cardiovascular repair, and neurological regeneration therapies.

Paracrine Signaling

Step 2 of 3: Paracrine signaling

Stem cells release bioactive molecules—cytokines, growth factors, and exosomes—that communicate with nearby cells. This signaling promotes tissue repair, reduces inflammation, and recruits other cells to help with healing.

Molecular Messengers: Stem cells secrete powerful signaling molecules that instruct surrounding cells to begin repair processes.

Cellular Recruitment: These signals attract and activate other healing cells, creating a coordinated repair response.

Anti-Inflammatory Action: Paracrine factors reduce harmful inflammation while promoting beneficial healing responses. Hypoxic priming further improves the immunomodulatory potency of MSC-derived extracellular vesicles, an important consideration for exosome manufacturing.^[4]

Immunomodulation

Step 3 of 3: Immunomodulation

MSCs and certain other stem cells can modulate immune responses. They suppress excessive inflammation and promote an anti-inflammatory environment, benefiting conditions like arthritis, inflammatory bowel disease, and other autoimmune diseases. UCT-WJ-MSCs exert this bidirectional, context-dependent immunomodulation uniquely suited to chronic inflammatory and autoimmune conditions — unlike pharmaceutical immunosuppressants that globally ablate immune function, MSC immunomodulation is locally responsive, triggered by inflammatory signals and self-limiting as inflammation resolves.

Immune Balance: Via PGE2, IDO, IL-10, and TGF-β, WJ-MSCs suppress CD4+ and CD8+ T-cell proliferation and activation,^[5] ^[6] while driving differentiation of CD4+FoxP3+ regulatory T-cells (Tregs) that maintain self-tolerance.^[7] MSCs also suppress NK cell proliferation and cytotoxicity, contributing to reduced immune clearance in allogeneic settings — though activated NK cells retain some capacity to lyse unconditioned MSCs.^[8]

Autoimmune Treatment: Particularly effective for conditions where the immune system attacks healthy tissue, such as rheumatoid arthritis and multiple sclerosis. The MSC secretome shifts macrophage phenotype from inflammatory M1 to anti-inflammatory M2, promoting tissue repair over destruction, and inhibits dendritic cell maturation to prevent downstream autoimmune cascade initiation.

Chronic Disease Management: Provides long-term benefits for managing chronic inflammatory conditions and improving quality of life. Systematic review and meta-analysis of MSC transplantation across autoimmune and rheumatic immune diseases confirms this safety and efficacy profile.^[9]

Homing & Engraftment: After IV infusion, UCT-WJ-MSCs express CXCR4 and migrate along SDF-1 chemokine gradients produced at sites of tissue injury, concentrating cells at therapeutic targets. Engraftment is typically transient (days to weeks), during which intensive paracrine secretion occurs — the transient nature of engraftment supports safety, with no risk of ectopic differentiation or long-term off-target effects.

Mitochondrial Donation: A recently characterized mechanism is direct mitochondrial transfer from MSCs to injured cells via tunneling nanotubes and extracellular-vesicle-packaged mitochondria. UCT-WJ-MSC mitochondria, confirmed high ΔΨm (membrane potential), restore ATP production in energy-depleted cells in ischemic heart, kidney, and neural tissues, with preclinical evidence of benefit in cardiac hibernation and acute ischemic injury models.^[10]

Clinical Benefits

Clinical benefits

Reference for therapeutic mechanisms, common advantages of MSC-based approaches, how Akira products compare by source, and bioactive factors in perinatal tissue. Use alongside product specs and your own protocols.

Related: Overview • Research landscape

Therapeutic Context

Stem cells in regenerative programs

Stem cells function as the body's master cells, possessing remarkable abilities to self-renew and differentiate into specialized cell types including nerve, bone, cartilage, and muscle tissue. While embryonic stem cells offer pluripotency, they raise significant ethical concerns and tumor formation risks.

Adult stem cells, while safer, demonstrate limited differentiation capacity. Perinatal stem cells, particularly Umbilical Cord Tissue Mesenchymal Stem Cells (UCT-MSCs), represent the optimal balance of potency, safety, and ethical sourcing.

Reduce Systemic Inflammation: MSCs secrete anti-inflammatory cytokines that modulate inflammatory cascades across multiple organ systems.

Promote Tissue Regeneration: MSCs stimulate localized repair processes through paracrine signaling and direct differentiation into needed cell types.

Modulate Immune Response: MSCs regulate T-cell function, preventing autoimmune damage while preserving necessary immune surveillance.

Therapy Advantages

Why stem cell therapy matters

Hallmark advantages clinicians and scientists evaluate across therapeutic areas when using stem cell products in research.

Tissue Regeneration: Stem cells regenerate damaged tissues, providing solutions for injuries, degenerative diseases, and organ damage.
Anti-Inflammatory Effects: Particularly MSCs, can reduce inflammation in conditions like arthritis, autoimmune diseases, and inflammatory bowel disease.
Reduced Scar Formation: By encouraging healthy tissue formation, stem cells minimize fibrosis and scarring, which benefits wound healing and aesthetic applications.
Lower Risk of Rejection: Since MSCs are "immune privileged," they can be used in allogeneic (donor-derived) settings without triggering an immune response.
Non-Invasive Collection: Perinatal-derived MSCs are collected from tissues that do not require invasive procedures, making them accessible and ethically sound.
Versatility in Applications: Stem cells can be applied across multiple medical disciplines, from orthopedics to neurology and dermatology, making them adaptable to a wide range of therapeutic needs.

Bioactives

Key components in perinatal tissue

Beyond MSCs, umbilical cord, amniotic fluid, and placenta carry additional bioactive factors that can influence therapeutic readouts.

Exosomes: Vesicles carrying proteins, lipids, and RNA molecules that promote cellular repair, immune modulation, and anti-inflammatory effects.
Growth Factors and Cytokines: Molecules that stimulate tissue repair and regeneration, regulate cell growth, and reduce inflammation.
Hyaluronic Acid: Retains moisture, supporting skin elasticity and joint lubrication.
Collagen: A structural protein in connective tissue that aids in skin firmness, wound healing, and joint support.
Anti-Inflammatory Proteins: Proteins like IL-10 and TGF-β help control inflammation.
Fibronectin and Laminin: Extracellular matrix proteins that support wound healing and tissue repair.
Peptides and Amino Acids: Essential nutrients for cell growth and skin health.

Akira vs Competition

Akira MSCs vs common alternatives

Glucose-based cryopreservation (no DMSO) with post-thaw viability up to 95–98%. Flow cytometry confirms MSC markers (CD90+, CD73+, CD105+) and absence of hematopoietic markers (CD34-, CD45-, HLA-DR-).

Source	Limitations	Akira approach
Bone Marrow MSCs	Invasive collection, aged cells, reduced differentiation potential	Young, potent UCT-MSCs with superior expansion capacity
Adipose MSCs	Lower purity, risk of contamination, variable quality	Highly pure, consistently manufactured cell populations
Cord Blood	Limited MSC yield, higher immunogenicity	Abundant MSCs with enhanced immune privilege properties
iPSCs	Risk of genetic mutation and tumor formation	Natural cells with stable genome and safety profile

Applications

Potential applications across body systems

Akira UCT-WJ-MSCs engage host tissue through three mechanistic pillars — paracrine secretion, immunomodulation, and direct differentiation — supporting research across a broad range of indications.

Musculoskeletal & Rheumatologic: Knee osteoarthritis (intra-articular injection — cartilage matrix support, synovial inflammation reduction, with secretome-based cartilage regeneration confirmed in an animal model of early-stage OA^[11]), rheumatoid arthritis, ankylosing spondylitis (UC-MSC infusion improved BASDAI disease-activity scores in a pilot trial^[12]), systemic lupus erythematosus, and psoriasis/psoriatic arthritis via T-cell suppression, Treg expansion, and M1→M2 macrophage polarization.

Metabolic & Endocrine: Type 1 diabetes (beta cell protection via immunomodulation of autoreactive T-cells), type 2 diabetes/metabolic syndrome — meta-analysis supports MSC therapy as a possible treatment approach,^[13] non-alcoholic steatohepatitis (anti-fibrotic HGF signaling), and Hashimoto's thyroiditis — thyroid parenchyma inflammation and autoantibody reduction shown in rat models.^[14]

Neurologic & Neuropsychiatric: Multiple sclerosis (Treg expansion, BBB stabilization, remyelination support), ALS — motor neuron survival extension via BDNF/GDNF/IGF-1 secretion, with ALSFRS-R progression stabilized or decreased in ~80% of patients in a retrospective case-control study of intrathecal WJ-MSC therapy,^[15] stroke/TBI (BBB stabilization, neurogenesis induction — intercellular mitochondrial transfer is an emerging endogenous neuroprotective mechanism in ischemic stroke^[10]), and autism spectrum disorder research supported by emerging preclinical and early clinical evidence.^[16]

Cardiac & Pulmonary: Acute myocardial infarction (intracoronary or IV infusion — LVEF improvement, cardiomyocyte salvage), chronic heart failure — myocardial remodeling suppression, VEGF-mediated revascularization, and significant NT-proBNP reduction demonstrated in the HUC-HEART randomized controlled trial,^[17] and IPF/COPD — AT2 epithelial support, anti-fibrotic HGF/PGE2 signaling, with MSC-derived extracellular vesicles shown to attenuate pulmonary vascular permeability and lung injury from hemorrhagic shock and trauma^[18] and MSC therapy for cardiac inflammation supported by immunomodulatory and toll-like-receptor-mediated mechanisms.^[19]

GI, Renal & Oncologic: Crohn's disease/ulcerative colitis — mucosal regeneration, TNF-α suppression, with fistula healing demonstrated in inflammatory bowel disease,^[20] graft-versus-host disease (steroid-refractory management; Phase I trial registered as NCT03158896^[21]), and chronic kidney disease (tubular epithelial repair via HGF/Met, podocyte protection).

Anti-Aging & Systemic Wellness: SASP suppression from young, non-senescent donor MSCs — MSCs are increasingly recognized as both a target and driver of inflammaging research,^[22] with galangin-preconditioned MSC exosomes shown to attenuate oxidative-stress-induced senescence and promote geriatric wound healing;^[23] systemic rejuvenation of circulating growth factors and tissue repair capacity; and resolution of persistent post-COVID inflammatory, fibrotic, and autoimmune sequelae, consistent with the broader safety profile established across MSC clinical trials.^[24]

These are experimental use cases, provided as a scientific reference for researchers. Except where noted, they did not use Akira Biotech materials, and results may not be reproducible with ours. Akira Biotech supplies laboratory reagents for research use only. Our products are NOT approved by FDA or any regulatory authority and are not for use in or on humans.

Clinical Evidence

Clinical evidence

Study / Trial	N / Design	Endpoints	Key Finding
WJ-MSC Knee OA Systematic Review^[25]	n=97 patients, 134 knees, 6 studies	VAS, WOMAC, KOOS, IKDC; 3–48 month follow-up	Significant pain and function improvement across all metrics; no serious adverse events; multiple-injection protocols superior to single injection
GvHD Phase I (NCT03158896)^[26]	n=10, steroid-refractory acute GvHD	ORR, complete response, safety	70% overall response rate; 40% complete response — substantially exceeding historical benchmarks for second-line steroid-refractory GvHD therapies
T1DM UC-MSC RCT^[27]	n=27 treated, n=26 control, 1-year RCT	Clinical remission, C-peptide, HbA1c	40.7% clinical remission in the MSC group vs. 0% in controls; 3 subjects achieved complete insulin independence for 3–12 months
AMI WJ-MSC RCT^[28]	n=116, multicenter RCT, 18-month follow-up	LVEF, LVESV, LVEDV, safety	+7.8% absolute LVEF vs. +2.8% placebo (P=0.001); significant LV volume reduction; no immune reactions or arrhythmias
Post-COVID ARDS RCT (NCT04390152)^[29]	n=100, double-blind RCT, 28-day follow-up	Mortality, lung CT score	UC-MSC significantly reduced 28-day mortality and improved lung CT infiltration scores vs. placebo

No serious adverse events attributable to WJ-MSC were reported across the Phase I/II GvHD, cardiac, and diabetes trials reviewed, and long-term follow-up (up to 48 months in KOA studies) shows sustained benefit without late adverse effects.

Research Landscape

Current state of stem cell research

Explore the latest breakthroughs and ongoing research in stem cell therapy. From cardiovascular regeneration to neurological disorders, discover how stem cells are revolutionizing modern medicine — an active field of literature review and synthesis as the evidence base matures.^[30] ^[31]

Related: Overview • Clinical benefits

Research Stats

Scale of stem cell science today

A snapshot of how broadly stem cells are studied and where they may apply across medicine.

Metric	Detail
100+ Treatable Conditions	Potential applications across medical disciplines
8 Medical Fields	Research being conducted from orthopedics to neurology
500+ Successful Trials	Potential applications across medical disciplines

Research Outlook

Looking to the future

The stem cell field keeps moving — regulation, technology, cost, and evidence are all shifting how therapies reach patients.

Regulatory Landscape: The FDA regulates stem cell therapies to ensure safety and efficacy, limiting some therapies, especially ESCs and iPSCs, while MSCs and adult stem cells see broader acceptance.

Advances in Technology: Gene editing, bioprinting, and scaffold engineering are enhancing stem cell therapy, improving integration and growth in damaged tissues.

Cost Reduction: Efforts to streamline extraction, culturing, and delivery aim to make treatments accessible. "Off-the-shelf" allogeneic therapies are reducing costs and increasing availability.

Increasing Evidence: Clinical trials and studies support the safety and efficacy of stem cell therapies, aiding mainstream acceptance and regulatory approval.

Research Areas

Where the science is concentrated

Major fronts where stem cell research is translating into clinical impact and ongoing trials.

Cardiology: Research focuses on repairing heart tissue after heart attacks and improving blood flow.
Neurology: MSCs offer potential for neurodegenerative conditions like Parkinson's & Alzheimer's.
Hair Restoration: MSCs and exosomes stimulate hair growth, offering a non-surgical option for hair loss.
Sexual Wellness: MSCs improve blood flow and tissue health in the genital area.
Orthopedics and Musculoskeletal: MSCs are used for joint injuries, cartilage damage, and conditions like osteoarthritis.
Autoimmune Diseases: MSCs help manage autoimmune conditions by balancing immune responses.
Dermatology and Aesthetics: Used for skin rejuvenation, wound healing, and scar reduction.
General Health and Wellness: Therapies are explored for reducing inflammation, supporting immune health, and improving vitality.

Next Steps

Next steps

Continue exploring regenerative science with Akira Biotech.

View products • Speak with our team

Mesenchymal Stem Cells